NCT06355973
Not Yet Recruiting
N/A
A Pilot Study for Efficacy of Cognitive and Physical Training in Patients With Mild Cognitive Impairment
MinYoung Kim, MD, PhD0 sites24 target enrollmentApril 2024
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Patients With Mild Cognitive Impairment (MCI)
- Sponsor
- MinYoung Kim, MD, PhD
- Enrollment
- 24
- Primary Endpoint
- Montreal Cognitive Assessment (MoCA)
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
This is to find out the effectiveness of cognitive and physical function training for patients with mild cognitive impairment.
It is for the prevention and treatment of dementia in the future. randomized, Pilot Study.
Investigators
MinYoung Kim, MD, PhD
Sponsor-Investigator
Bundang CHA Hospital
Eligibility Criteria
Inclusion Criteria
- •men and women aged 60 or older
- •A person who falls within the abnormal range of the Montreal Cognitive Assessment (MoCA) test
- •a person who can independently carry out daily life
- •If the subject or legal representative voluntarily decides to participate and agrees in writing to comply with the precautions after hearing and fully understanding the detailed explanation of this clinical study
Exclusion Criteria
- •A person diagnosed with Alzheimer's dementia or other causes (stroke, brain tumor, cerebral palsy, dementia, Parkinson's disease, etc.)
- •A person with unstable cardiovascular system, digestive system, respiratory system, endocrine system, etc. and poor general condition
- •Patients who have participated in other treatment clinical studies or who have participated in other treatment clinical studies within the last 30 days
- •Other cases where the researcher determines that participation in this clinical study is not appropriate
Outcomes
Primary Outcomes
Montreal Cognitive Assessment (MoCA)
Time Frame: screening - 6 weeks - 3 months
K-MoCA is a measure of memory loss or other symptoms of cognitive decline. It includes 30 questions and a task that takes about 12 minutes to complete. The score can range from 0 to 30. A score of 26 or higher is considered normal.
Secondary Outcomes
- Clinical Global Impressions of Change (CGIC)(Baseline - 6 weeks- 3months)
- Geriatric Quality of Life-Dementia (GQOL-D)(Baseline - 6 weeks- 3months)
- Geriatric Depression Scale (GDSd)(Baseline - 6 weeks- 3months)
- Global Deterioration Scale (GDS)(Baseline - 3months)
- Clinical Dementia Rating (CDR)(Baseline - 3months)
- Korean-Mini Mental Status Examination (K-MMSE)(Baseline - 6 weeks - 3months)
- Berg Balance Scale (BBS)(Baseline - 6 weeks- 3months)
- Instrumental Activities of Daily Living (I-ADL)(Baseline - 6 weeks- 3months)
- Electroencephalography(Baseline - 6 weeks- 3months)
Similar Trials
Unknown
Phase 3
Cognitive Function After Stem Cell TransplantationFatigueCognitive ImpairmentStem Cell TransplantationNCT00884338Charite University, Berlin, Germany60
Unknown
Phase 3
Effectiveness of a Cognitive and Physical Intervention to Reduce Head and Muscle Pain in a Large PopulationMigraineTension Type HeadacheCervical PainNCT01050972University of Turin, Italy15,000
Recruiting
N/A
The Pilot Study of Medical Device-Neuclare for Patients With Mild Cognitive Disorder and Early DementiaDementia, MildCognitive Disorder MildNCT05633095Deepsonbio20
Completed
Phase 2
Pilot Study of an Intervention Involving Cognitive Training and tDCS in Morbidly Obese SubjectsObesity, MorbidObesity (BMI > 35) and Diabetes MellitusObesity (BMI > 35) and High Blood PressureObesity (BMI > 35) and DyslipemiaNCT03943979Parc de Salut Mar18
Terminated
N/A
Cognitive-Behavioral and Physical Activity Interventions for Binge Eating and OverweightBinge-Eating DisorderBinge EatingOverweight and ObesityNCT03777189Yale University4